Inter-domain dynamics drive cholesterol transport by NPC1 and NPC1L1 proteins
Preprint
Abstract
Transport of LDL-derived cholesterol from lysosomes into the cytoplasm requires NPC1 protein; NPC1L1 mediates uptake of dietary cholesterol. We introduced single disulfide bonds into NPC1 and NPC1L1 to explore the importance of inter-domain dynamics in cholesterol transport. Using a sensitive method to monitor lysosomal cholesterol efflux, we find that NPC1’s N-terminal domain need not release from the rest of the protein for efficient cholesterol export. Either introducing single disulfide bonds to constrain lumenal/extracellular domains or shortening a cytoplasmic loop abolishes transport activity by both NPC1 and NPC1L1. The widely prescribed cholesterol uptake inhibitor, Ezetimibe, blocks NPC1L1; we show that interface residues that lie at the interface between NPC1L1’s three extracellular domains comprise the drug’s binding site. These data support a model in which cholesterol passes through the cores of NPC1/NPC1L1 proteins; concerted movement of various domains is needed for transfer and Ezetimibe blocks transport by binding to multiple domains simultaneously.Keywords
All Related Versions
- Published version: eLife, 9.
This publication has 53 references indexed in Scilit:
- Computational Tools Unravel Putative Sterol Binding Sites in the Lysosomal NPC1 ProteinJournal of Chemical Information and Modeling, 2019
- Use of mutant 125 I-Perfringolysin O to probe transport and organization of cholesterol in membranes of animal cellsProceedings of the National Academy of Sciences, 2013
- Niemann–Pick type C 1 function requires lumenal domain residues that mediate cholesterol-dependent NPC2 bindingProceedings of the National Academy of Sciences, 2011
- Mechanism of Cholesterol Transfer from the Niemann-Pick Type C2 Protein to Model Membranes Supports a Role in Lysosomal Cholesterol TransportJournal of Biological Chemistry, 2006
- Niemann-Pick C1 Like 1 Protein Is Critical for Intestinal Cholesterol AbsorptionScience, 2004
- Structure of a cholesterol-binding protein deficient in Niemann–Pick type C2 diseaseProceedings of the National Academy of Sciences, 2003
- Ezetimibe, a Potent Cholesterol Absorption Inhibitor, Inhibits the Development of Atherosclerosis in ApoE Knockout MiceArteriosclerosis, Thrombosis, and Vascular Biology, 2001
- A smooth particle mesh Ewald methodThe Journal of Chemical Physics, 1995
- A Receptor-Mediated Pathway for Cholesterol HomeostasisScience, 1986
- CHARMM: A program for macromolecular energy, minimization, and dynamics calculationsJournal of Computational Chemistry, 1983